NTM and Bronchiectasis: Research and Treatment Update | 3-25-2022 | Dialogue with a Doc series

preview_player
Показать описание
Presented by:
Charles L. Daley, MD
Chief, Division of Mycobacterial & Respiratory Infections
Professor, Department of Medicine
National Jewish Health

Nontuberculous mycobacterial (NTM) infections, a non-contagious cousin of tuberculosis, has shown a marked increase in the U.S. population in recent years. Many NTM patients also develop bronchiectasis, a condition that inhibits the ability to naturally clear mucus and bacteria from the airways and puts individuals at ever-increasing risk of infection.
Рекомендации по теме
Комментарии
Автор

An excellent, relevant & current discussion that all can leverage to effectively communicate re pulmonary bronchiectasis, auto/immune involvement (Eg. RA; Allergy/Asthma), NTM v LTBI, and whether to treat or watch/wait. Team NJH, please know that your commitment to excellence in healthcare & pulmonary medicine is greatly appreciated. Thank You! 🕊

HeyMJ.
Автор

Learning about this condition helps understand the treatment, thank you.

helentrammell
Автор

Thank you for all the information gave me
Some hope

jennylinden
Автор

BCG is useful to treat or ameliorate MAC infection

leonardeuler